Intrinsic Value of S&P & Nasdaq Contact Us

NeuroPace, Inc. NPCE NASDAQ

NASDAQ Global Market • Healthcare • Medical - Devices • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$19.00
+23.8%

NeuroPace, Inc. (NPCE) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 9 recommend buying, 1 recommend holding, and 0 recommend selling.

The analyst consensus price target for NPCE is $19.00, representing a +23.8% upside from the current price of $15.35. Price targets range from a low of $16.00 to a high of $22.00.

Analyst Consensus — NPCE

Buy
Strong Buy
0
Buy
9
Hold
1
Sell
0
Strong Sell
0
10 analysts
Price Targets
Consensus$19.00
High$22.00
Low$16.00
Median$19.00
Last Month Avg-
Last Quarter Avg$19.00
Last Year Avg$18.80
All-Time Count11
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message